Transferrin receptor regulation in Parkinson's disease and MPTP-treated mice.
Mash
D C
DC
Department of Neurology, University of Miami School of Medicine, Florida 33141.
Sanchez-Ramos
J
J
Weiner
W J
WJ
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000494:pharmacology*; D000818:Animals; D002352:Carrier Proteins / Q000502:physiology; D050483:Dopamine Plasma Membrane Transport Proteins; D005978:Glutathione / Q000502:physiology; D006801:Humans; D007501:Iron / Q000378:metabolism; D015227:Lipid Peroxidation / Q000187:drug effects / Q000502:physiology; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D051379:Mice; D009410:Nerve Degeneration / Q000187:drug effects / Q000502:physiology; D009419:Nerve Tissue Proteins; D010300:Parkinson Disease / Q000503:physiopathology*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000503:physiopathology*; D011990:Receptors, Transferrin / Q000187:drug effects / Q000502:physiology*; D013378:Substantia Nigra / Q000187:drug effects / Q000503:physiopathology
D002352:Carrier Proteins; D050483:Dopamine Plasma Membrane Transport Proteins; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D011990:Receptors, Transferrin; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D007501:Iron; D005978:Glutathione